- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Results
11
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
11 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NWRN | CHF 9.35 | 4.0% | 22.4% | CHF 186.6m | CHF 13.71 | PS28.3x | E42.8% | n/a | ||
COPN | CHF 64.80 | 0.6% | 4.3% | CHF 1.0b | CHF 98.37 | PE15.8x | E21.5% | 2.9% | ||
SKAN | CHF 79.20 | 5.0% | 0.3% | CHF 1.8b | CHF 90.67 | PE55.2x | E17.8% | 0.4% | ||
SDZ | CHF 42.50 | 3.5% | 47.7% | CHF 18.6b | CHF 44.38 | PS2x | E29.7% | 1.0% | ||
GALD | CHF 109.24 | -0.09% | n/a | CHF 26.0b | CHF 101.82 | PS6.6x | E36.4% | n/a | ||
BSLN | CHF 39.45 | -4.9% | 16.7% | CHF 478.2m | CHF 77.25 | PS3.2x | E14.9% | 0% | ||
LONN | CHF 583.20 | 6.5% | 57.5% | CHF 42.1b | CHF 636.81 | PE73.5x | E21.1% | 0.7% | ||
PPGN | CHF 27.00 | 8.7% | 80.1% | CHF 890.6m | CHF 36.16 | PS2.9x | E64.9% | 0% | ||
TECN | CHF 227.40 | 0.8% | -30.2% | CHF 2.9b | CHF 283.83 | PE28.8x | E13.9% | 1.3% | ||
BANB | CHF 58.65 | 4.9% | 5.2% | CHF 4.4b | CHF 76.00 | PE38.7x | E17.8% | 1.4% | ||
SFZN | CHF 994.00 | 2.1% | 16.5% | CHF 4.3b | CHF 1,167.67 | PE33.1x | E13.0% | 0.4% |
Page 1 of 1